Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2022-05-12 | Donald A. Wuchterl is listed as a Director and Named Executive Officer with beneficial ownership of shares but no specific age, committees, or compensation details are provided. |
| 2022-07-11 | Donald A. Wuchterl, 52, became a director on April 14, 2021 and currently serves as member of the Nominating and Corporate Governance Committee. Since April 2021, Mr. Wuchterl has served as Senior Vice President and Chief Manufacturing Officer at T-knife Therapeutics, a next-generation T-cell receptor company developing innovative therapeutics for the benefit of solid tumor patients where he is responsible for all Chemistry, Manufacturing and Controls (“CMC”) functions. From 2016 to 2021, Mr. Wuchterl served as Senior Vice President, Technical Operations and Quality at Audentes Therapeutics (an Astellas Company), a gene therapy company focused on developing and commercializing innovative products for patients living with serious, life-threatening rare neuromuscular diseases. From 2012 to 2016, Mr. Wuchterl served as Senior Vice President and Chief Operating Officer at Cytovance Biologics, a leading biopharmaceutical contract manufacturing company. Prior to Cytovance, Mr. Wuchterl held positions of increasing responsibility with Dendreon, Shire HGT, Amgen, Biogen Idec and Roche. Mr. Wuchterl has a B.S. in Business Administration from Colorado Technical University and an M.B.A. from Fitchburg State University. Mr. Wuchterl’s qualifications to serve on Abeona’s board include his over 29 years of experience in the life sciences industries, with senior roles in operations and CMC across several different product types. He also brings significant experience building out and leading new cGMP organizations and facilities. |
| 2023-04-13 | Donald A. Wuchterl, 53, became a director on April 14, 2021 and currently serves as member of the Nominating and Corporate Governance Committee. ... Donald A. Wuchterl 57,500 37,386 94,886 |
| 2024-03-19 | Donald A. Wuchterl 54 Director Since April 2021 ... Donald A. Wuchterl currently serves as member of the Nominating and Corporate Governance Committee and the Audit Committee. ... Donald A. Wuchterl 59,375 271,143 - 330,518 |
| 2024-11-12 | The table below represents the compensation paid to each of our directors who served on the Board during the year ended December 31, 2023. |
Data sourced from SEC filings. Last updated: 2025-08-30